Doctor&Cols — colectivo de mentoría dental
Producción científica2025· Dentistry Journal

Clinical Performance of Subperiosteal Implants in the Full-Arch Rehabilitation of Severely Resorbed Edentulous Jaws: A Systematic Review and Metanalysis

★ Alto impactoQ1 · DentistryImpact Factor · 3.289

AutoresLuis Sánchez‐Labrador, Santiago Bazal-Bonelli, Fabián Pérez‐González, Tomás Beca-Campoy, Carlos Cobo-Vázquez, Jorge Cortés‐Bretón Brinkmann, José María Martínez González

Abstract

Background/Objectives: Subperiosteal implants (SPIs) were first used in the 1940s, but due to their complications and the rise of dental implants, they were discontinued. Thanks to new technologies and new materials, nowadays they are being used again and studied as a treatment for severe bone defects. This review analyzes the clinical results—survival rates and complications—of SPIs used to support full arch rehabilitations of severely resorbed maxillae and mandibles, comparing the outcomes resulting from implant placement conducted in one or two surgical interventions. Methods: An automated search was conducted in four databases (Medline/Pubmed, Scopus, Web of Science, and Cochrane Library), as well as a manual search for relevant clinical articles published before 28 February 2025. The review included human studies with at least four patients, in which SPIs were placed to restore full-arch edentulous maxillae and mandibles. Quality of evidence was evaluated using the Newcastle–Ottawa Quality Assessment Scale and the Joanna Briggs Institute Critical Appraisal tool. Results: A total of 14 studies met the inclusion criteria and were included for analysis, including 958 patients and 973 SPIs. The survival rate was 100% when one surgical intervention was performed and 85% when two interventions were performed after 4–38 months and 3–22 years follow-up, respectively. Conclusions: SPIs would appear to offer a good alternative for patients with severe bone atrophies, especially SPIs fabricated using digital techniques in a single step, presenting promising survival rates and a low complication rate, although more randomized clinical trials with long-term follow-up are needed.

Autor Doctor&Cols

Educational Partners